# Deferoxamine for the Prevention of Cardiac Surgery-Associated Acute Kidney Injury

> **NCT04633889** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 320 (actual)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DRUG:** Deferoxamine
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT04633889
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-04-13
- **Primary completion:** 2024-08-26
- **Final completion:** 2026-08-01
- **Target enrollment:** 320 (ACTUAL)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04633889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04633889, "Deferoxamine for the Prevention of Cardiac Surgery-Associated Acute Kidney Injury". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04633889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*